| Immunological considerations for COVID-19 vaccine strategies M Jeyanathan, S Afkhami, F Smaill, MS Miller, BD Lichty, Z Xing Nature Reviews Immunology 20 (10), 615-632, 2020 | 1198 | 2020 |
| Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus DF Stojdl, B Lichty, S Knowles, R Marius, H Atkins, N Sonenberg, JC Bell Nature medicine 6 (7), 821-825, 2000 | 1079 | 2000 |
| VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents DF Stojdl, BD Lichty, JM Paterson, AT Power, S Knowles, R Marius, ... Cancer cell 4 (4), 263-275, 2003 | 972 | 2003 |
| Going viral with cancer immunotherapy BD Lichty, CJ Breitbach, DF Stojdl, JC Bell Nature Reviews Cancer 14 (8), 559-567, 2014 | 682 | 2014 |
| Vesicular stomatitis virus: re-inventing the bullet BD Lichty, AT Power, DF Stojdl, JC Bell Trends in molecular medicine 10 (5), 210-216, 2004 | 440 | 2004 |
| Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy MC Bourgeois-Daigneault, DG Roy, AS Aitken, N El Sayes, NT Martin, ... Science translational medicine 10 (422), eaao1641, 2018 | 309 | 2018 |
| Intelligent design: combination therapy with oncolytic viruses K Ottolino-Perry, JS Diallo, BD Lichty, JC Bell, JA McCart Molecular Therapy 18 (2), 251-263, 2010 | 268 | 2010 |
| The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus DF Stojdl, N Abraham, S Knowles, R Marius, A Brasey, BD Lichty, ... Journal of virology 74 (20), 9580-9585, 2000 | 256 | 2000 |
| Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 S Afkhami, MR D’Agostino, A Zhang, HD Stacey, A Marzok, A Kang, ... Cell 185 (5), 896-915. e19, 2022 | 247 | 2022 |
| Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity AT Power, J Wang, TJ Falls, JM Paterson, KA Parato, BD Lichty, DF Stojdl, ... Molecular Therapy 15 (1), 123-130, 2007 | 235 | 2007 |
| Targeting tumor vasculature with an oncolytic virus CJ Breitbach, NS De Silva, TJ Falls, U Aladl, L Evgin, J Paterson, YY Sun, ... Molecular Therapy 19 (5), 886-894, 2011 | 223 | 2011 |
| Potentiating cancer immunotherapy using an oncolytic virus BW Bridle, KB Stephenson, JE Boudreau, S Koshy, N Kazdhan, ... Molecular Therapy 18 (8), 1430-1439, 2010 | 218 | 2010 |
| Maraba virus as a potent oncolytic vaccine vector JG Pol, L Zhang, BW Bridle, KB Stephenson, J Rességuier, S Hanson, ... Molecular therapy 22 (2), 420-429, 2014 | 195 | 2014 |
| A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication RE Edge, TJ Falls, CW Brown, BD Lichty, H Atkins, JC Bell Molecular Therapy 16 (8), 1437-1443, 2008 | 179 | 2008 |
| Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity CS Ilkow, M Marguerie, C Batenchuk, J Mayer, D Ben Neriah, ... Nature medicine 21 (5), 530-536, 2015 | 165 | 2015 |
| Getting oncolytic virus therapies off the ground JC Bell, B Lichty, D Stojdl Cancer cell 4 (1), 7-11, 2003 | 162 | 2003 |
| Synergistic interaction between oncolytic viruses augments tumor killing F Le Boeuf, JS Diallo, JA McCart, S Thorne, T Falls, M Stanford, F Kanji, ... Molecular Therapy 18 (5), 888-895, 2010 | 159 | 2010 |
| Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand KL Mossman, MF Mian, NM Lauzon, CL Gyles, B Lichty, R Mackenzie, ... The Journal of Immunology 181 (10), 6702-6706, 2008 | 144 | 2008 |
| Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production N Gill, PM Deacon, B Lichty, KL Mossman, AA Ashkar Journal of virology 80 (20), 9943-9950, 2006 | 140 | 2006 |
| Cigarette smoke impacts immune inflammatory responses to influenza in mice CS Robbins, CMT Bauer, N Vujicic, GJ Gaschler, BD Lichty, EG Brown, ... American journal of respiratory and critical care medicine 174 (12), 1342-1351, 2006 | 137 | 2006 |
